MorphoSys AG (MOR)
Aug 5, 2024 - MOR was delisted (reason: voluntary delisting)
18.96
+0.45 (2.43%)
Inactive · Last trade price
on Aug 2, 2024
MorphoSys AG Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for MorphoSys AG stock had an average target of 12.13, with a low estimate of 4.75 and a high estimate of 18.25.
Analyst Consensus: Hold
* Price targets were last updated on Mar 14, 2024.
Analyst Ratings
The average analyst rating for MorphoSys AG stock from 5 stock analysts was "Hold". This means that analysts believed this stock was likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 | Aug '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy → Hold Downgrades $17 → $18 | Buy → Hold | Downgrades | $17 → $18 | -3.74% | Mar 14, 2024 |
| Wells Fargo | Wells Fargo | Buy Reiterates $17 | Buy | Reiterates | $17 | -10.34% | Feb 5, 2024 |
| Morgan Stanley | Morgan Stanley | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jan 19, 2024 |
| Morgan Stanley | Morgan Stanley | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Jan 16, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $10 → $17 | Buy | Maintains | $10 → $17 | -10.34% | Dec 15, 2023 |
Financial Forecast
Revenue This Year
234.49M
from 238.28M
Decreased by -1.59%
Revenue Next Year
307.62M
from 234.49M
Increased by 31.19%
EPS This Year
-4.38
from -1.38
EPS Next Year
-3.35
from -4.38
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 303.5M | 387.5M | 529.8M | ||
| Avg | 234.5M | 307.6M | 449.1M | ||
| Low | 120.1M | 150.4M | 380.6M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 27.4% | 65.2% | 72.2% | ||
| Avg | -1.6% | 31.2% | 46.0% | ||
| Low | -49.6% | -35.9% | 23.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | -1.72 | -0.37 | 2.97 | |
| Avg | -4.38 | -3.35 | -1.19 | |
| Low | -9.90 | -6.57 | -4.57 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | - | - | - | |
| Avg | - | - | - | |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.